Matthew Gline

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.

Get IMVT alerts

About Matthew Gline

Matthew Gline is recorded as CEO at Immunovant, Inc. (IMVT). Matthew Gline has spoken on 1 earnings call across 1 company, most recently for Immunovant, Inc. on November 7, 2024. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.

Matthew Gline on recent calls

“So not at all a quiet quarter for us given that we put out both the Graves' data and the Phase III data for brepocitinib in DM.”

CEO, Immunovant, Inc. Q2 FY2025 Earnings Call · November 7, 2024

Affiliation history

Immunovant, Inc. (IMVT)
CEO

Source not stated

Current

Company network

Immunovant, Inc.

IMVT

Current role

Biotechnology · Healthcare

CEO

1 appearance Latest appearance 2024-11-07

View calls and events

Leadership on record at Immunovant, Inc.

Recent activity

Earnings call Immunovant, Inc. Q2 FY2025 Earnings Call Immunovant, Inc. (IMVT)
2024-11-07